Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Glauser

Showing results (221-230 of 243) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1996
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centersM Oethinger, S Conrad, K Kaifel, et al.
Swiss Medical Weekly|February 24, 2001
CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumoniaI de Werra, G Zanetti, C Jaccard, et al.
The Journal of Infectious Diseases|May 1, 1990
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J D Baumgartner, G E Grau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDSP Deplazes, A Mathis, M van Saanen, et al.
Journal of Inflammation|January 1, 1995
Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteriaS Lengacher, C V Jongeneel, D Le Roy, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerA Cometta, S Zinner, R de Bock, et al.
Nature Medicine|February 2, 2000
Protection from septic shock by neutralization of macrophage migration inhibitory factorT Calandra, B Echtenacher, D L Roy, et al.
Immunity|September 1, 1994
CD14 is a pattern recognition receptorJ Pugin, I D Heumann, A Tomasz, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1988
Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trialsJ Klastersky, S H Zinner, T Calandra, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
Pageof 25

Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|February 1, 1996
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centersM Oethinger, S Conrad, K Kaifel, et al.
Swiss Medical Weekly|February 24, 2001
CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumoniaI de Werra, G Zanetti, C Jaccard, et al.
The Journal of Infectious Diseases|May 1, 1990
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study GroupT Calandra, J D Baumgartner, G E Grau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Dual microsporidial infection due to Vittaforma corneae and Encephalitozoon hellem in a patient with AIDSP Deplazes, A Mathis, M van Saanen, et al.
Journal of Inflammation|January 1, 1995
Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteriaS Lengacher, C V Jongeneel, D Le Roy, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1995
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerA Cometta, S Zinner, R de Bock, et al.
Nature Medicine|February 2, 2000
Protection from septic shock by neutralization of macrophage migration inhibitory factorT Calandra, B Echtenacher, D L Roy, et al.
Immunity|September 1, 1994
CD14 is a pattern recognition receptorJ Pugin, I D Heumann, A Tomasz, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1988
Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trialsJ Klastersky, S H Zinner, T Calandra, et al.
Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.
Pageof 25